The store will not work correctly when cookies are disabled.
(2R)-2-(tert-butylamino)-1-(3-chlorophenyl)-2,3,3,3-tetradeuterio-propan-1-one
ID: ALA5219205
Chembl Id: CHEMBL5219205
PubChem CID: 44199755
Max Phase: Preclinical
Molecular Formula: C13H18ClNO
Molecular Weight: 239.75
Associated Items:
Names and Identifiers
Canonical SMILES: [2H]C([2H])([2H])[C@@]([2H])(NC(C)(C)C)C(=O)c1cccc(Cl)c1
Standard InChI: InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3/t9-/m1/s1/i1D3,9D
Standard InChI Key: SNPPWIUOZRMYNY-FJKVMUFJSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 239.75 | Molecular Weight (Monoisotopic): 239.1077 | AlogP: 3.30 | #Rotatable Bonds: 3 |
Polar Surface Area: 29.10 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.22 | CX LogP: 3.27 | CX LogD: 2.39 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.82 | Np Likeness Score: -0.88 |
References
1. Shi Y, Dinh J, Pelletier R, Raccor B, Yusuff N, Morgan AJ, Harbeson S, Uttamsingh V, Totah RA.. (2022) Selective deuteration of bupropion slows epimerization and reduces metabolism., 76 [PMID:36174836] [10.1016/j.bmcl.2022.129009] |